Lumo leverages advanced machine learning to reduce calibration time, and flag low-confidence response factor predictions.
To our knowledge, this study is the first to apply deep learning models that can, beyond diagnosis, identify molecular subtypes and predict outcomes in a single brain tumour entity (meningioma) using ...
Everything we saw at Microsoft Build 2026.
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する